Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.7K citations

Medicine, Oncology, Pharmacology +13

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

Medicine, Oncology, Pharmacotherapy +16

A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.

Xinyu Fu, Fiorella Guadagni, Robert M. Hoffman · Proceedings of the National Academy of Sciences · 1992 · 379 citations · Full text

Medicine, Oncology, Pathology +17

Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens.

Xiuping Fu, Jeffrey M. Besterman, Anna Z. Monosov et al. · Proceedings of the National Academy of Sciences · 1991 · 370 citations

Medicine, Cancer Biology, Oncology +16

Transcription Analysis of Human Equilibrative Nucleoside Transporter-1 Predicts Survival in Pancreas Cancer Patients Treated with Gemcitabine

Elisa Giovannetti, Mario Del Tacca, Valentina Mey et al. · Cancer Research · 2006 · 347 citations · Full text

Medicine, Oncology, Pharmacology +16